Higher doses of opioids in patients who need palliative sedation prior to death: Cause or consequence?

European Journal of Cancer

Volumn 47, Issue 15, 2011, Pages 2341-2346

  Oosten, A W ^a   Oldenmenger, W H ^a   Van Zuylen, C ^a   Schmitz, P I M ^a   Bannink, M ^a   Lieverse, P J ^a   Bromberg, J E C ^a   Van Der Rijt, C C D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Analgesics; Delirium; Opioid; Pain; Palliative care; Terminal care

Indexed keywords

AMITRIPTYLINE; FENTANYL; HALOPERIDOL; HYDROMORPHONE; KETAMINE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL;

ADJUVANT THERAPY; ADULT; AGED; ANALGESIA; ANXIETY; ARTICLE; CANCER PATIENT; DEATH; DELIRIUM; DRUG EFFICACY; DRUG MEGADOSE; DYSPNEA; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PALLIATIVE THERAPY; PREVALENCE; PRIORITY JOURNAL; RESTLESSNESS; RETROSPECTIVE STUDY; SEDATION; TERMINAL CARE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; DELIRIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS; NETHERLANDS; PAIN MEASUREMENT; PAIN, INTRACTABLE; PALLIATIVE CARE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TERMINAL CARE; TIME FACTORS;

EID: 80053362486     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.06.057     Document Type: Article

References (29)

1. The Hospice and Palliative Nurses Association. In: http://www.hpna.org.
2. P. Claessens, J. Menten, P. Schotsmans, and B. Broeckaert Palliative sedation: a review of the research literature J Pain Symptom Manage 36 3 2008 310 333
3. A. Elsayem, E. Curry Iii, and J. Boohene Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center Support Care Cancer 17 1 2009 53 59
4. H.C. Muller-Busch, I. Andres, and T. Jehser Sedation in palliative care - a critical analysis of 7 years experience BMC Palliat Care 2 1 2003 2
5. S. Mercadante, G. Intravaia, and P. Villari Controlled sedation for refractory symptoms in dying patients J Pain Symptom Manage 37 5 2009 771 779
6. H. Kohara, H. Ueoka, H. Takeyama, T. Murakami, and T. Morita Sedation for terminally ill patients with cancer with uncontrollable physical distress J Palliat Med 8 1 2005 20 25 (Pubitemid 40144248)
7. J.A. Rietjens, A. van der Heide, and A.M. Vrakking Physician reports of terminal sedation without hydration or nutrition for patients nearing death in the Netherlands Ann Intern Med 141 3 2004 178 185
8. J.G. Hasselaar, S.C. Verhagen, and A.P. Wolff Changed patterns in Dutch palliative sedation practices after the introduction of a national guideline Arch Intern Med 169 5 2009 430 437
9. R. Forde, O.G. Aasland, E. Falkum, H. Breivik, and S. Kaasa Palliative sedation to dying patients in Norway Tidsskr Nor Laegeforen 121 9 2001 1085 1088 (Pubitemid 33709583)
10. J.A. Rietjens, L. van Zuylen, and H. van Veluw Palliative sedation in a specialized unit for acute palliative care in a cancer hospital: comparing patients dying with and without palliative sedation J Pain Symptom Manage 36 3 2008 228 234
11. C. White, M.A. McCann, and N. Jackson First do no harm. Terminal restlessness or drug-induced delirium J Palliat Med 10 2 2007 345 351 (Pubitemid 46740207)
12. P.G. Lawlor, B. Gagnon, and I.L. Mancini Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study Arch Intern Med 160 6 2000 786 794 (Pubitemid 30165239)
13. J.D. Gaudreau, P. Gagnon, F. Harel, M.A. Roy, and A. Tremblay Psychoactive medications and risk of delirium in hospitalized cancer patients J Clin Oncol 23 27 2005 6712 6718 (Pubitemid 46190266)
14. J.D. Gaudreau, P. Gagnon, M.A. Roy, F. Harel, and A. Tremblay Opioid medications and longitudinal risk of delirium in hospitalized cancer patients Cancer 109 11 2007 2365 2373 (Pubitemid 46801569)
15. Cancer pain relief and palliative care Report of a WHO Expert Committee World Health Organ Tech Rep Ser 804 1990 1 75
16. M.J. Schuurmans, L.M. Shortridge-Baggett, and S.A. Duursma The Delirium Observation Screening Scale: a screening instrument for delirium Res Theory Nurs Pract 17 1 2003 31 50
17. Diagnostiek en behandeling van pijn bij patiënten met kanker. CBO, VIKC (Eds.), Van Zuiden Communications B.V., Alphen a/d Rijn; 2008.
18. R.K. Portenoy, and P. Lesage Management of cancer pain Lancet 353 9165 1999 1695 1700 (Pubitemid 29224537)
19. C. Quigley, and P. Wiffen A systematic review of hydromorphone in acute and chronic pain J Pain Symptom Manage 25 2 2003 169 178
20. C.H. Wilder-Smith, J. Schimke, B. Osterwalder, and H.J. Senn Oral tramadol, a mu-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain Ann Oncol 5 2 1994 141 146
21. P.W. Walker, S. Palla, and B.L. Pei Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med 11 8 2008 1103 1108
22. T. Wolff, H. Samuelsson, and T. Hedner Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration Pain 62 2 1995 147 154
23. T. Wolff, H. Samuelsson, and T. Hedner Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients Pain 68 2-3 1996 209 216 (Pubitemid 27025877)
24. P. Klepstad, O. Dale, F. Skorpen, P.C. Borchgrevink, and S. Kaasa Genetic variability and clinical efficacy of morphine Acta Anaesthesiol Scand 49 7 2005 902 908 (Pubitemid 41076330)
25. M. Ashby, B. Fleming, M. Wood, and A. Somogyi Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients J Pain Symptom Manage 14 3 1997 157 167 (Pubitemid 27377599)
26. P.J. Tiseo, H.T. Thaler, and J. Lapin Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients Pain 61 1 1995 47 54
27. T. Morita, Y. Tei, J. Tsunoda, S. Inoue, and S. Chihara Increased plasma morphine metabolites in terminally ill cancer patients with delirium: an intra-individual comparison J Pain Symptom Manage 23 2 2002 107 113 (Pubitemid 34158642)
28. M.M. Wood, M.A. Ashby, A.A. Somogyi, and B.G. Fleming Neuropsychological and pharmacokinetic assessment of hospice inpatients receiving morphine J Pain Symptom Manage 16 2 1998 112 120 (Pubitemid 28400161)
29. Klepstad P, Fladvad T, Skorpen F, et al. Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients. Pain 2011.